You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
22 July 2026 - Animal health company Zoetis Inc (NYSE: ZTS) announced on Wednesday that it has launched Portela (relfovetmab) in Canada and European Union member states, introducing the first long-acting anti-nerve growth factor monoclonal antibody t...
22 July 2026 - Elephas Biosciences Corporation, developer of an innovative live tissue platform for immunotherapy response prediction, announced on Tuesday that it has entered into an international partnership with life sciences company Invitrocue Pt...
21 July 2026 - India-based global pharmaceutical company Lupin Limited (BSE: 500257) (NSE: LUPIN) announced on Tuesday the strategic spin-out of two oncology programmes, LNP7457 (PRMT5) and LNP8701 (SOS1), through its wholly owned subsidiary, Lupin I...
21 July 2026 - Fuse Oncology, a structured AI platform for radiation oncology, announced on Monday the launch of FuseRx, a prescribing and treatment-intent solution for radiation oncology.According to Fuse Oncology, FuseRx is the keystone of the Fuse...
21 July 2026 - Clinical-stage biopharmaceutical company AbelZeta Pharma Inc announced on Monday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted PRIority MEdicines (PRIME) designation f...
20 July 2026 - Personalis Inc (Nasdaq: PSNL), a provider of advanced genomics for precision oncology, announced on Monday that it has agreed to be acquired by technology firm Tempus AI Inc (NASDAQ: TEM) in a transaction valued at approximately USD1.5...
20 July 2026 - Biotechnology company Sareum Holdings plc (AIM: SAR) announced on Monday that it has completed dosing in the Phase 2-enabling toxicology programme for SDC-1801, its selective oral TYK2/JAK1 inhibitor being developed for autoimmune dise...